Perspectives

The Patient Voices panel at Cancer Progress 2025 was both a reckoning and a rallying cry. What began as personal storytelling quickly deepened into systemic critique—and ultimately, a blueprint for progress. It was a challenge to redefine whose experiences count in drug development and when their voices are allowed to matter.

Explore best-practice considerations for integrated evidence generation planning (IEGP) enriched with real-world case studies that illustrate the consequences of both success and failure in evidence planning. Learn how a strategic approach can transform evidence from a cost center to a strategic accelerator – cutting costs, shortening time-to-evidence, and boosting stakeholder trust with unified narratives validated by real-world impact.